ImmunotiX 500 By XYMOGEN EP Overview & Drug Interactions

Check For Interactions With ImmunotiX 500

Supplement: ImmunotiX 500 by XYMOGEN EP

ImmunotiX 500 Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with ImmunotiX 500 by XYMOGEN EP

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 60
UPC/BARCODE 871149001483

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Whole Glucan Particle
500 mg
Beta-Glucans --

Other Ingredients:
HPMC
dicalcium phosphate anhydrous
Stearic Acid
Magnesium Stearate
Silica
Medium-Chain Triglycerides


Label Statments:


General Statements
- Beta 1,3/1,6 glucan is a unique complex carbohydrate purified from Saccharomyces cerevisiae (baker's yeast). It is natural, non-genetically modified (non-GMO), hypoallergenic, patented, and generally recognized as safe (GRAS). Taken orally, ImmunotiX 500 primes and mobilizes the cells that support the body's first-line immune response.
- EXCLUSIVE PATENTED
- PATENTED 1,3/1,6 WHOLE GLUCAN PARTICLE Clinically Tested Worldwide
- PHARMACEUTICAL GRADE PROFESSIONAL USE ONLY
- This package is completely recyclable
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Precautions
- CAUTIONS: Consult your healthcare practitioner before use.
- Keep out of reach of children.
- Avoid if allergic to any ingredient.
- Children and pregnant or lactating women should consult their healthcare practitioner prior to use.
- Children and pregnant or lactating women should consult their healthcare practitioner prior to use.
- Do not use if tamper seal is damaged.
Storage
- STORAGE: Keep tightly closed in a cool, dry place.
Formulation
- DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast protein, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or preservatives
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- MAY BE COVERED BY ONE OR MORE OF THE FOLLOWING PATENTS AND APPLICATIONS: US 7,981,447; US 7,022,685; US 7,566,704; US 6,639,216; US 5,702,719 and patents pending.
- All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.
- (C) 2012 XYMOGEN
- ImmunotiX 500(TM) delivers 500 mg of whole glucan particle per capsule, providing beta 1,3/1,6 glucan - that's double the dose of ImmunotiX 250(TM).
Seals/Symbols
- Vegetable CAPSULES
Suggested/Recommended/Usage/Directions
- DIRECTIONS: For ongoing immune support: Take one capsule daily, first thing int he morning or last thing at night (before or well after a meal), with a full 8 oz glass of water. For fast-acting immune support: Take up to two capsules per day, as above; or use as directed by your healthcare practitioner.
General
- ZLB-IMMUNI-01 REV. 091312

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN Exclusive Professional Formulas
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.